Dabigatran etexilate
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Dabigatran Etexilate is a generic anticoagulant medication that helps prevent blood clots by inhibiting thrombin, a key clotting factor. Available as oral capsules in 75mg, 110mg, and 150mg strengths, it's prescribed for conditions like atrial fibrillation or after certain surgeries. Manufactured by Hetero Labs Ltd. III and others, it's a prescription drug. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Dabigatran etexilate
Access the FDA dataset for Dabigatran etexilate β ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025